Literature DB >> 30955521

Pulmonary Embolism.

Eno-Obong Essien1, Parth Rali2, Stephen C Mathai3.   

Abstract

Venous thromboembolism (VTE) includes pulmonary embolism (PE) and deep vein thrombosis. PE is the third most common cause of cardiovascular death worldwide after stroke and heart attack. Management of PE has evolved recently with the availability of local thrombolysis; mechanical extraction devices; hemodynamic support devices, like extracorporeal membrane oxygenation; and surgical embolectomy. There has been development of multidisciplinary PE response teams nationwide to optimize the care of patients with VTE. This review describes the epidemiology of PE, discusses diagnostic strategies and current and emerging treatments for VTE, and considers post-PE follow-up care.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deep vein thrombosis (DVT); Pulmonary embolism (PE); Pulmonary embolism response team; Venous thromboembolism (VTE)

Mesh:

Year:  2019        PMID: 30955521     DOI: 10.1016/j.mcna.2018.12.013

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  23 in total

1.  Risk factors of pulmonary embolism in the elderly patients: a retrospective study.

Authors:  Yuxia Ma; Yi Liu; Ying Zhi; Haibin Wang; Mei Yang; Jieting Niu; Li Zhao; Pengsheng Wang
Journal:  Aging Clin Exp Res       Date:  2022-01-10       Impact factor: 3.636

2.  The safety and efficacy of systemic versus catheter-based therapies: application of a prognostic model by a pulmonary embolism response team.

Authors:  Jean-Pierre Iskandar; Essa Hariri; Christopher Kanaan; Nicholas Kassis; Hayaan Kamran; Denise Sese; Colin Wright; Mark Marinescu; Scott J Cameron
Journal:  J Thromb Thrombolysis       Date:  2021-09-29       Impact factor: 2.300

3.  Changes of serum P62 and Beclin 1 in patients with pulmonary embolism during treatment and their predictive value for efficacy.

Authors:  Xuehui Zhang; Liu Huang; Lijiang Shao; Xuxia Chen; Jinguo Chu; Xueqin Chen
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

4.  Gadolinium Enhances Dual-energy Computed Tomography Scan of Pulmonary Artery.

Authors:  An Xie; Wen-Jie Sun; Yan-Feng Zeng; Peng Liu; Jian-Bin Liu; Feng Huang
Journal:  Curr Med Sci       Date:  2022-09-30

5.  Plasma skeletal muscle myosin phenotypes identified by immunoblotting are associated with pulmonary embolism occurrence in young adults.

Authors:  Taichi K Deguchi; Hiroshi Deguchi; Zihan Guo; Darlene J Elias; John H Griffin
Journal:  Thromb Res       Date:  2020-02-27       Impact factor: 3.944

Review 6.  Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin.

Authors:  Hiroshi Deguchi; Shravan Morla; John H Griffin
Journal:  J Thromb Haemost       Date:  2020-10-25       Impact factor: 5.824

7.  Risk Factors for Pulmonary Embolism in ICU Patients: A Retrospective Cohort Study from the MIMIC-III Database.

Authors:  Cheng-Bin Huang; Chen-Xuan Hong; Tian-Hao Xu; Ding-Yun Zhao; Zong-Yi Wu; Liang Chen; Jun Xie; Chen Jin; Bing-Zhang Wang; Lei Yang
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

8.  Hypereosinophilia with Concurrent Venous Thromboembolism: Clinical Features, Potential Risk Factors, and Short-term Outcomes in a Chinese Cohort.

Authors:  Yecheng Liu; Xu Meng; Jun Feng; Xianliang Zhou; Huadong Zhu
Journal:  Sci Rep       Date:  2020-05-20       Impact factor: 4.379

Review 9.  Severe pulmonary tuberculosis complicated with insidious pulmonary thromboembolism: a case report and literature review.

Authors:  Lili Huang; Chunyang Yin; Xiaoyan Gu; Xiaojun Tang; Xia Zhang; Chunmei Hu; Wei Chen
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

10.  Prognosis and risk factors in older patients with lung cancer and pulmonary embolism: a propensity score matching analysis.

Authors:  Liu Junjun; Wang Pei; Yan Ying; Song Kui
Journal:  Sci Rep       Date:  2020-01-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.